Quiet diplomacy as Australia navigates global pricing pressure, but can it work?

According to the spokesperson, "The department is engaging with sponsors to address these concerns, where possible, in line with current policy and legislation, including the advice of the independent Pharmaceutical Benefits Advisory Committee." …